MENU
PRODUCTS R&D
> PRODUCTS R&DR&D Team
Reber Genetics has a strong R&D team with capabilities in both conventional vaccine development and novel biotechnology-based approaches. Specifically, the team has expertise in veterinary pathology, drug formulation, genetic recombination, protein engineering, microbial and viral expression system development, molecular biology, enteric oral vaccine development and biochemical immunoassay.
Reber supplements its own technical capabilities with relationships with some of the leading research institutions including Agricultural Technology Research Institute (Taiwan), Development Center for Biotechnology (Taiwan), Biomedical Center of Industrial Technology Research Institute (Taiwan), National Taiwan University (Taiwan), National Chiayi University (Taiwan), National Pingtung University of Science and Technology (Taiwan), Fooyin University (Taiwan), Johns Hopkins University (USA) and Kansas University (USA), . These relationships have proven beneficial in aiding Reber’s vaccine development.
Reber supplements its own technical capabilities with relationships with some of the leading research institutions including Agricultural Technology Research Institute (Taiwan), Development Center for Biotechnology (Taiwan), Biomedical Center of Industrial Technology Research Institute (Taiwan), National Taiwan University (Taiwan), National Chiayi University (Taiwan), National Pingtung University of Science and Technology (Taiwan), Fooyin University (Taiwan), Johns Hopkins University (USA) and Kansas University (USA), . These relationships have proven beneficial in aiding Reber’s vaccine development.
